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Abstract
Introduction We investigated whether baseline CT angiogra-
phy (CTA) and CT perfusion (CTP) in acute ischemic stroke
could improve prediction of infarct presence and infarct
volume on follow-up imaging.
Methods We analyzed 906 patients with suspected anterior
circulation stroke from the prospective multicenter Dutch
acute stroke study (DUST). All patients underwent baseline
non-contrast CT, CTA, and CTP and follow-up non-contrast
CT/MRI after 3 days. Multivariable regression models were
developed including patient characteristics and non-contrast
CT, and subsequently, CTA and CTP measures were added.
The increase in area under the curve (AUC) and R2 was
assessed to determine the additional value of CTA and CTP.
Results At follow-up, 612 patients (67.5 %) had a detectable
infarct on CT/MRI; median infarct volume was 14.8 mL
(interquartile range (IQR) 2.8–69.6). Regarding infarct pres-
ence, the AUC of 0.82 (95 % confidence interval (CI) 0.79–
0.85) for patient characteristics and non-contrast CT was im-
proved with addition of CTA measures (AUC 0.85 (95 % CI
Electronic supplementary material The online version of this article
(doi:10.1007/s00234-015-1636-z) contains supplementary material,
which is available to authorized users.
* Tom van Seeters
T.vanSeeters@umcutrecht.nl
1 Department of Radiology, University Medical Center Utrecht,
Heidelberglaan 100, HP E01.132 3584 CX Utrecht, The Netherlands
2 Department of Neurology, Brain Center Rudolf Magnus, University
Medical Center Utrecht, Utrecht, The Netherlands
3 Department of Radiology, Academic Medical Center,
Amsterdam, The Netherlands
4 Department of Radiology, St. Antonius Hospital,
Nieuwegein, The Netherlands
5 Department of Neurology, St. Antonius Hospital,
Nieuwegein, The Netherlands
6 Department of Radiology, Leiden University Medical Center,
Leiden, The Netherlands
7 Department of Neurology, Leiden University Medical Center,
Leiden, The Netherlands
8 Department of Radiology, Catharina Hospital,
Eindhoven, The Netherlands
9 Department of Neurology, Catharina Hospital,
Eindhoven, The Netherlands
10 Department of Radiology, VU University Medical Center,
Amsterdam, The Netherlands
11 Department of Neurology, VU University Medical Center,
Amsterdam, The Netherlands
12 Department of Radiology, Erasmus MC University Medical Center,
Rotterdam, The Netherlands
Neuroradiology (2016) 58:327–337
DOI 10.1007/s00234-015-1636-z
0.82–0.87); p<0.001) and was even higher after addition of
CTP measures (AUC 0.89 (95 % CI 0.87–0.91); p<0.001)
and combined CTA/CTP measures (AUC 0.89 (95 % CI
0.87–0.91); p<0.001). For infarct volume, adding combined
CTA/CTP measures (R2 = 0.58) was superior to patient
characteristics and non-contrast CT alone (R2=0.44) and to
addition of CTA alone (R2 =0.55) or CTP alone (R2=0.54; all
p<0.001).
Conclusion In the acute stage, CTA and CTP have additional
value over patient characteristics and non-contrast CT for
predicting infarct presence and infarct volume on follow-up
imaging. These findings could be applied for patient selection
in future trials on ischemic stroke treatment.
Keywords Ischemic stroke . Prediction . CTangiography .
CT perfusion . Infarct volume
Introduction
Ischemic stroke is a major cause of death and disability world-
wide [1]. In patients with clinical features of acute ischemic
stroke, the underlying cause should be identified and different
treatment options should be weighed in order to start optimal
treatment as quickly as possible. Patient-specific information
on expected infarct volume could improve the choice of acute
therapy, as infarct volume is a frequently used outcome mea-
sure in intervention trials [2, 3] and is associated with clinical
outcome [4–7].
CT angiography (CTA) and CT perfusion (CTP) can pro-
vide important diagnostic, etiologic, and also prognostic in-
formation in patients with acute ischemic stroke. CTA offers
the possibility to determine the presence of an intracranial
occlusion, to assess the leptomeningeal collateral circulation,
and to visualize the endovascular access through the cervical
arteries [8–12]. CTP is used to obtain measures of brain per-
fusion and to differentiate reversible ischemia (penumbra)
from the irreversibly damaged infarct core [11–16]. In a pre-
vious study, we showed that CTA and CTP measures were
strong predictors of clinical outcome [17], though in multivar-
iable prediction models, their prognostic value in addition to
easier-to-obtain measures, i.e., patient characteristics and non-
contrast CT (NCCT), was limited. However, it is unclear
whether CTA and CTP measures can help to predict both
presence of an infarct and infarct volume on follow-up
imaging.
The aim of the present study was to investigate whether
baseline CTA and CTP measures in acute ischemic stroke
patients can improve prediction of infarct presence and infarct
volume on follow-up imaging when added to baseline patient
characteristics and NCCT.
Methods
Study population
All patients participated in the Dutch acute stroke study
(DUST), a prospective observational cohort study in six uni-
versity and eight non-university hospitals in The Netherlands.
A detailed description of the DUST study protocol has been
published previously [18]. The DUST study population con-
sists of patients (n=1476) with symptoms of acute ischemic
stroke of less than 9-h duration, who were enrolled between
May 2009 and August 2013. Patients with another diagnosis
than probable ischemic stroke on admission NCCT were ex-
cluded. All patients underwent NCCT, CTA, and CTP on
admission and follow-up NCCT if possible. Ethical approval
was obtained from the medical ethics committee of the Uni-
versity Medical Center Utrecht, The Netherlands, in addition
to local approval from all participating hospitals. Informed
consent was obtained from patients or their legal representa-
tive. The medical ethics committee waived the need for in-
formed consent for patients who died before informed consent
could be obtained.
For the present study, we selected patients who had a clin-
ical suspicion of anterior circulation stroke at admission. This
was determined by a neurologist in the acute stage and was
defined as either total anterior circulation syndrome (TACS),
partial anterior circulation syndrome (PACS), or lacunar syn-
drome (LACS) [19]. Additional exclusion criteria for the
328 Neuroradiology (2016) 58:327–337
13 Department of Neurology, Erasmus MC University Medical Center,
Rotterdam, The Netherlands
14 Department of Radiology, Rijnstate Hospital,
Arnhem, The Netherlands
15 Department of Neurology, Rijnstate Hospital,
Arnhem, The Netherlands
16 Department of Radiology, Medical Center Haaglanden, The
Hague, The Netherlands
17 Department of Neurology, Medical Center Haaglanden, The
Hague, The Netherlands
18 Department of Radiology, St. Elisabeth Hospital,
Tilburg, The Netherlands
19 Department of Neurology, St. Elisabeth Hospital,
Tilburg, The Netherlands
20 Department of Neurology, Academic Medical Center,
Amsterdam, The Netherlands
21 Department of Radiology, Radboud University Medical Center,
Nijmegen, The Netherlands
22 Department of Radiology, St. Franciscus Hospital,
Rotterdam, The Netherlands
23 Julius Center for Health Sciences and Primary Care, University
Medical Center Utrecht, Utrecht, The Netherlands
present study were absence of follow-up imaging and time
between admission and follow-up imaging <12 h or >14 days.
Candidate predictors
Candidate predictors were divided in patient characteristics,
NCCT predictors, CTA predictors, and CTP predictors. Ad-
mission scans were assessed by one of three observers with at
least 5 years of experience in neurovascular imaging, blinded
for all clinical information except for the side of symptoms.
Patient characteristics and NCCT predictors
Patient characteristics were collected at baseline and included
age, stroke severity determined by the National Institutes of
Health Stroke Scale (NIHSS) [20], time between symptom
onset and imaging, blood glucose level (mmol/L), and infor-
mation on treatment with intravenous thrombolysis with re-
combinant tissue-type plasminogen activator (IV-rtPA), intra-
arterial thrombolysis, or mechanical thrombectomy [21–24].
On NCCT, the presence of a hyperdense vessel sign was re-
corded and early ischemic changes were assessed with the
Alberta Stroke Program Early CT Score (ASPECTS) [25–28].
CTA predictors
CTA measures were ASPECTS on CTA source images, a
proximal intracranial arterial occlusion (either distal internal
carotid artery or M1 segment of the middle cerebral artery),
poor leptomeningeal collaterals (≤50% collateral filling of the
affected territory), and >70 % stenosis or occlusion of the
internal carotid artery ipsilateral to the affected hemisphere
[8–11, 28–32].
CTP predictors
CTP measures were ASPECTS on cerebral blood volume
(CBV) and mean transit time (MTT) maps, penumbra area
(cm2), and infarct core area (cm2) [15, 28, 33, 34]. Penumbra
and infarct core areas were calculated using previously report-
ed MTT and CBV thresholds [34]. We accounted for differ-
ences in CTP coverage by using the sum of penumbra and
infarct core areas on the two ASPECTS levels, as CTP cover-
age included those levels in all patients.
Study outcome
The first study outcome was presence of infarct on follow-up
imaging. The default follow-up imaging modality was NCCT
after 3 days or at the time of clinical deterioration or earlier
discharge. Follow-up MRI was used if this had been per-
formed for clinical reasons instead of NCCT. The second
study outcome was infarct volume (in mL). This was obtained
by manually delineating the hypodense infarcted area(s) on
axial NCCT slices and hyper-intense area(s) on axial DWI
slices on MRI. The surface of these area(s) was subsequently
multiplied by the slice thickness to obtain the infarct volume.
Observers were blinded for admission CTA and CTP when
they delineated the infarcts. Clinical outcome was assessed at
90 days using the modified Rankin Scale (mRS) [35].
Analyses
Univariable analyses
Logistic regression was used to determine the relation be-
tween each of the patient characteristics and CT predictors
and presence of infarct on follow-up imaging. This was
expressed as an odds ratio with 95 % confidence interval
(CI). We also calculated the positive predictive value (PPV)
for all predictors, indicating the probability of infarct presence
if a predictor was abnormal. Single imputation was performed
to account for missing data. Continuous predictors were trun-
cated at the first and 99th percentile to minimize the effect of
outliers [36].
Multivariable analyses
To investigate whether CTA and CTP would improve the
prognostic value of patient characteristics and NCCT predic-
tors, four different multivariable logistic regression models
were fitted to predict infarct presence on follow-up imaging.
The first model contained patient characteristics and NCCT
(model 1). In the subsequent two models, either CTA mea-
sures (model 2a) or CTP measures (model 2b) were added to
the first model. In the final model, both CTA and CTP mea-
sures were added to the first model (model 3). Shrinkage of
the model coefficients was performed to correct for optimism,
and the optimal shrinkage factor was determined by bootstrap
resampling with 1000 bootstrap samples [36]. Performance of
the models was assessed with receiver operator characteristic
(ROC) analyses and corresponding area under the curve
(AUC) values, which indicate the ability to differentiate be-
tween patients with and without an infarct on follow-up im-
aging. Differences in AUC were tested for statistical signifi-
cance [37].
To assess the additional value of CTA and CTP for predic-
tion of infarct volume, we used Tobit (censored) regression
analyses [38, 39]. Tobit regression is useful for situations
where the dependent variable is either 0 or above (but not
below), as is the case for infarct volume in our study. In one
single step, it determines both the probability of infarct vol-
ume being above 0 mL and changes in infarct volume when it
is above 0 mL [40]. The results of the Tobit regression anal-
yses are expressed as beta coefficients with 95 % CI. Differ-
ences between the Tobit models were determined with
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likelihood ratio tests. We explored the possibility of analyzing
our data with linear regression. However, the conditions for
linear regression were not fulfilled as the residuals were not
normally distributed and residual regression plots suggested
that there was no homoscedasticity. We then performed anal-
yses after transformation of the infarct volume including nat-
ural logarithm, square, cube, square root, cube root, and recip-
rocal transformations. As the conditions for linear regression
were also not fulfilled after these transformations, we consid-
ered linear regression not suitable for our data.
To assess whetherMRI assessment instead of NCCTwould
affect our findings, we repeated the analyses after excluding
patients with MRI as follow-up modality.
Finally, we determined whether infarct volume on follow-
up imaging was predictive for clinical outcome. Statistical
significance was tested with the Kruskal-Wallis test. All anal-
yses were performed with R version 3.0.2.
Results
After applying the inclusion and exclusion criteria, 906 pa-
tients remained for the analyses (Fig. 1). The mean age was
67.4±13.8 years, 527 patients (58.2 %) were male, and the
median NIHSS was 7 (interquartile range (IQR) 4–13). IV-
rtPA was given to 579 patients (63.9 %), and 60 patients
(6.6 %) received intra-arterial treatment. Twenty-one patients
(2.3 %) received intra-arterial treatment without prior IV-rtPA.
The median interval between admission and follow-up imag-
ing was 2.9 days (IQR 1.9–3.7 days). Follow-up imaging was
performed with NCCT in 839 patients (92.6 %) andMRI in 67
patients (7.4 %). An infarct was detected in 612 patients
(67.5 %) on follow-up imaging, with a median infarct volume
of 14.8 mL (IQR 2.8–69.6). Infarct volumes were higher on
follow-up NCCT (15.6 mL (IQR 3.1–73.8)) than on follow-up
MRI (4.0 mL (IQR 1.0–26.8); p=0.001). Fifty-six patients
(6.2 %) had a posterior circulation infarct on follow-up imag-
ing, indicating clinical misclassification of suspected infarct
location at baseline. Additional patient characteristics can be
found in Table 1.
Prediction of infarct presence on follow-up imaging
Univariable analyses showed a strong relation between all
abnormal imaging measures at baseline and the presence of
an infarct on follow-up imaging (Table 2). For a random pa-
tient in our study, the probability of having an infarct on
follow-up imaging was 67.5 %, not taking any patient charac-
teristics or imaging findings into account. However, if one or
more imaging findings were abnormal, the probability that an
infarct was present increased to 85–100 %.
For the multivariable analyses, the following bootstrap-
derived shrinkage factors were applied to the model
coefficients: 0.92 for model 1, 0.88 for model 2a, 0.90 for
model 2b, and 0.84 for model 3. Model descriptions, coeffi-
cients, odds ratios, and AUC values are presented in Online
Table 1.
The basic prognostic model including patient characteris-
tics and NCCT (model 1) had a high predictive value for
infarct presence, indicated by an AUC value of 0.82 (95 %
CI 0.79–0.85). Stroke severity (NIHSS), presence of a
hyperdense vessel sign, and ASPECTS onNCCT had a strong
predictive value for infarct presence in this model (Online
Table 1). Addition of CTA measures to the basic model (mod-
el 2a) improved the predictive value, as shown by the AUC
value of 0.85 (95 % CI 0.82–0.87; p<0.001). In this model,
ASPECTS on CTA source images and presence of a proximal
intracranial occlusion were the strongest CTA predictors of
infarct presence on follow-up imaging. Addition of CTP mea-
sures alone (model 2b; AUC 0.89 (95 % CI (0.87–0.91)) or in
combination with CTA measures (model 3; AUC 0.89 (95 %
CI (0.87–0.91)) also improved the prognostic value when they
were added to the basic model (both p<0.001) and was supe-
rior to addition of CTA measures alone (both p<0.001). For
Patients included in the analyses
n=906
Patients with suspected anterior
circulation stroke
n=1134
Admission scans
irretrievable
n=83
All patients
n=1476
No suspected
anterior circulation
stroke
n=259
No follow-up
imaging performed
n=204
Follow-up >14
days or <12 hours
n=24
Fig. 1 Flowchart depicting the number of patients included in the study
and remaining for the analyses
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CTP, penumbra area and ASPECTS on CBV maps were in-
dependent predictors of infarct presence (Online Table 1). Ad-
dition of combined CTA and CTP measures was not superior
to addition of CTP measures alone (p=0.19). Results were
comparable when patients with follow-up MRI instead of
NCCT were excluded from the analyses and when patients
who had a posterior circulation infarct on follow-up imaging
were excluded.
We used the multivariable models to calculate the predicted
risk of infarct presence on follow-up imaging and divided
patients into tertiles of low, intermediate, and high predicted
risk. Next, we calculated for each tertile the actual proportion
of patients that had an infarct on follow-up imaging. As can be
seen in Table 3, the contrast between the low- and high-risk
tertiles was largest for the model including both CTA and CTP
measures: 28 versus 99 % presence of infarct at follow-up,
respectively. An example of an interactive calculation sheet to
make predictions for infarct presence and infarct volume for
individual patients is provided in Fig. 2 (see Online Table 3 for
the interactive calculation sheet).
Table 1 Patient characteristics
All patients No infarct on
follow-up
Infarct volume
<14.8 mLa
Infarct volume
≥14.8 mLa
Number of patients 906 (100.0) 294 (32.5) 306 (33.8) 306 (33.8)
Clinical measures
Age (years) 67.4 (13.8) 69.2 (13.3) 68.3 (13.5) 64.9 (14.2)
Male gender 527 (58.2) 154 (52.4) 178 (58.2) 195 (63.7)
Stroke severity (NIHSS) 7 (4–13) 4 (3–6) 6 (3–10) 13 (8–17)
Time from symptom onset to scan (minutes) 113 (72–180) 116 (74–172) 121 (75–197) 101 (67–170)
IV-rtPA 579 (63.9) 188 (63.9) 186 (60.8) 205 (67.0)
Intra-arterial thrombolysis or mechanical thrombectomy 60 (6.6) 3 (1.0) 17 (5.6) 40 (13.1)
Smoking 251 (29.6) 78 (28.3) 90 (30.9) 83 (29.6)
Glucose (mmol/L) 6.5 (5.8–7.8) 6.3 (5.6–7.3) 6.5 (5.7–7.8) 6.8 (6.1–8.3)
Systolic blood pressure (mmHg) 157 (29.0) 160 (29.2) 159 (30.4) 153 (26.8)
Diastolic blood pressure (mmHg) 85 (16.9) 86 (16.3) 87 (17.4) 84 (17.0)
Clinical stroke subtype
Total anterior circulation syndrome (TACS) 216 (23.8) 22 (7.5) 49 (16.0) 145 (47.4)
Partial anterior circulation syndrome (PACS) 539 (59.5) 184 (62.6) 202 (66.0) 153 (50.0)
Lacunar syndrome (LACS) 151 (16.7) 88 (29.9) 55 (18.0) 8 (2.6)
Non-contrast CT findings
Hyperdense vessel sign 204 (22.5) 7 (2.4) 46 (15.0) 151 (49.5)
Non-contrast CTASPECTS 10 (10–10) 10 (10–10) 10 (10–10) 10 (7–10)
CT angiography findings
CT angiography source images ASPECTS 10 (8–10) 10 (10–10) 10 (9–10) 7 (5–10)
Proximal intracranial occlusion 255 (28.6) 12 (4.1) 70 (23.5) 173 (57.1)
Poor collaterals 122 (13.7) 4 (1.4) 18 (6.1) 100 (33.1)
Significant ipsilateral carotid stenosis or occlusion 156 (17.5) 19 (6.6) 43 (14.4) 94 (31.0)
CT perfusion findings
Cerebral blood volume (CBV) ASPECTS 10 (7–10) 10 (10–10) 10 (9–10) 7 (5–8)
Mean transit time (MTT) ASPECTS 8 (4–10) 10 (10–10) 8 (5–10) 3 (1–6)
Penumbra area (cm2)b 23.0 (9.0–41.7) 15.3 (4.2–36.3) 18.8 (6.2–34.8) 26.9 (12.3–45.2)
Infarct core area (cm2)b 6.7 (1.5–21.0) 1.1 (0.0–5.0) 3.1 (0.4–6.9) 17.0 (5.2–32.5)
Clinical outcome
Poor outcome at 90 days (mRS 3–6) 344 (38.4) 65 (22.6) 94 (30.9) 185 (60.7)
Follow-up imaging
Infarct volume (mL) 3.0 (0.0–36.5) 0.0 (0.0–0.0) 2.8 (1.1–6.5) 69.6 (34.3–152.1)
All data are displayed as mean (standard deviation), median (interquartile range), or n (%).
aMedian split for infarct volume in patients with an infarct on follow-up imaging
b In patients with a perfusion deficit
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Table 2 Univariable analyses for
prediction of infarct presence on
follow-up imaging (n= 906)
Predictor OR 95 % confidence
interval
PPVa
(%)
Age (per decade) 0.87 0.78–0.97**
Lowest tertile (<62.3 years) 71
Middle tertile (62.3–74.0 years) 71
Highest tertile (≥74.0 years) 61
Stroke severity (NIHSS)
NIHSS 1–2 1.00 (ref) 46
NIHSS 3–4 1.17 0.77–1.78 50
NIHSS 5–7 2.18 1.47–3.24*** 65
NIHSS 8–13 6.94 4.14–11.64*** 86
NIHSS >13 22.04 10.70–45.39*** 95
Time from symptom onset to scan (per hour) 1.04 0.97–1.12
Lowest tertile (≤86 min) 69
Middle tertile (86–147 min) 67
Highest tertile (≥147 min) 66
Admission glucose level (per mmol/L) 1.08 1.01–1.15*
Lowest tertile (≤6.0 mmol/L) 58
Middle tertile (6.0–7.2 mmol/L) 71
Highest tertile (≥7.2 mmol/L) 74
IV-rtPA, intra-arterial thrombolysis, or mechanical thrombectomy 1.16 0.87–1.56 69
Non-contrast CT predictors
Hyperdense vessel sign 19.61 9.09–42.29*** 97
Non-contrast CTASPECTS (per point decrease) 9.77 4.21–22.67***
ASPECTS 10 59
ASPECTS 8–9 96
ASPECTS ≤7 100
CT angiography predictors
CT angiography source images ASPECTS (per point decrease) 3.47 2.48–4.86***
ASPECTS 10 53
ASPECTS 7–9 96
ASPECTS ≤6 98
Proximal intracranial occlusion 15.90 8.73–28.97*** 95
Poor collaterals 17.68 6.46–48.39*** 97
Significant ipsilateral carotid stenosis or occlusion 3.99 2.44–6.52*** 87
CT perfusion predictors
Cerebral blood volume (CBV) ASPECTS (per point decrease) 4.83 3.43–6.79***
ASPECTS 10 44
ASPECTS 7–9 95
ASPECTS ≤6 99
Mean transit time (MTT) ASPECTS (per point decrease) 1.77 1.61–1.95***
ASPECTS 10 29
ASPECTS 6–9 85
ASPECTS ≤5 94
Penumbra area (per SD; 19.9 cm2) 6.37 4.45–9.11***
0.0 cm2 34
0.0–18.1 cm2 89
>18.1 cm2 94
Infarct core area (per SD; 13.7 cm2) 38.86 16.18–93.34***
0.0 cm2 38
0.0–5.4 cm2 87
≥5.4 cm2 96
*p< 0.05; **p < 0.01; ***p < 0.001
a Prior probability of infarct presence is 67.5 %
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Prediction of infarct volume
CTA and CTP improved the prediction of infarct volume
when they were added to patient characteristics and NCCT
(Online Table 2). The models with addition of either CTA
measures (model 2a; R2 =0.55) or CTP measures (model 2b;
R2=0.54) were superior to the model with patient character-
istics and NCCT (model 1; R2=0.44; both p<0.001). Further-
more, addition of combined CTA and CTP measures (model
3; R2=0.58) was superior to addition of CTA or CTP alone
(both p<0.001). In the model including both CTA and CTP
measures, independent predictors of infarct volume were AS-
PECTS on NCCT, CTA source images, and CBV maps, poor
collaterals, ipsilateral ICA stenosis or occlusion, and infarct
core area. Results were comparable if patients with follow-up
MRI and patients with a posterior circulation infarct on
follow-up imaging were excluded from the analyses.
Infarct volume and clinical outcome
Patients with larger infarct volumes on follow-up imaging had
higher mRS scores at 90 days than patients with smaller infarct
volumes, while patients without a visible infarct on follow-up
imaging had the lowest mRS scores (Fig. 3; p<0.001).
Discussion
Our study shows that CTA and CTP have additional value
over patient characteristics and NCCT for predicting infarct
presence and infarct volume on follow-up imaging.
No other large prospective study has determined the addi-
tional value of CTA or CTP measures for prediction of infarct
presence and infarct volume on follow-up imaging, although
several studies investigated the prognostic value of individual
NCCT, CTA, or CTP measures. However, these studies most-
ly included preselected patient populations such as patients
fulfilling criteria for IV-rtPA [15], patients treated with intra-
arterial thrombolysis [41, 42], patients with a confirmed oc-
clusion [30, 42], patients with recanalization [42], or patients
with a confirmed ischemic stroke [14, 29, 30, 42]. The patients
in our study represent a cohort of all patients with a suspected
acute ischemic stroke in the anterior circulation. This means
that the patients in our study received different forms of treat-
ment including IV-rtPA, intra-arterial thrombolysis, or me-
chanical thrombectomy or none of these treatment options.
By using an unselected anterior circulation stroke population
and adding treatment as a covariate to the analyses, our results
are likely to be more generalizable to a broader stroke popu-
lation. We restricted our study population to patients with a
suspected anterior circulation stroke, because CTP thresholds
to determine penumbra and infarct core have not been validat-
ed for posterior circulation stroke and also because we expect-
ed that the relation between imaging measures and infarct
volume would be different for patients with anterior and pos-
terior circulation stroke. Nonetheless, 6 % of the patients in
our study had an infarct in the posterior circulation on follow-
up imaging. This percentage is consistent with previous liter-
ature and probably reflects difficulties in infarct localization
based on clinical information alone [43, 44]. However, it
could have led to a small underestimation of the coefficients
that we have found—especially for the imaging measures—as
Table 3 Actual risk of infarct
presence on follow-up imaging
according to tertiles of predicted
risk for the model with patient
characteristics and non-contrast
CT (model 1) and with additional
CT angiography (model 2a), CT
perfusion (model 2b), and
combined CT angiography and
CT perfusion measures (model 3)
Infarct on follow-up/n Percentage (%)
All patients 612/906 68
Model 1—patient characteristics and non-contrast CT
Lowest predicted risk tertile 119/302 39
Intermediate predicted risk tertile 200/302 66
Highest predicted risk tertile 293/302 97
Model 2a—addition of CT angiography
Lowest predicted risk tertile 107/302 35
Intermediate predicted risk tertile 210/302 70
Highest predicted risk tertile 295/302 98
Model 2b—addition of CT perfusion
Lowest predicted risk tertile 86/302 28
Intermediate predicted risk tertile 229/302 76
Highest predicted risk tertile 297/302 98
Model 3—addition of CT angiography and CT perfusion
Lowest predicted risk tertile 86/302 28
Intermediate predicted risk tertile 228/302 75
Highest predicted risk tertile 298/302 99
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they are more specifically focused on the anterior circulation
than patient characteristics.
Regarding the prognostic value of individual CTP and
CTA measures, previous studies were consistent with our re-
sults and identified ASPECTS on NCCT [8, 9, 29, 30], CTA
source images [8, 9, 30, 42], CBV maps [15, 42], and MTT
maps [15] as predictors of infarct volume. Other studies did
not use ASPECTS for assessment of CTP, but instead used
CBV volume at baseline to be a predictor of infarct volume
[14, 29]. The predictive value of collateral status for infarct
volume is also consistent with previous research [41]. A sig-
nificant stenosis or occlusion of the internal carotid artery,
ipsilateral to the suspected hemisphere, predicted a larger in-
farct volume in our study, but this was not examined in previ-
ous studies. The larger infarct volume in these patients may
result from failure of vasodilatative cerebral autoregulatory
mechanisms in patients with severe stenosis and subsequent
chronic hypoxic stress [45]. Successful recanalization is
known to result in a smaller final infarct volume [46]. How-
ever, we did not include this information in our prediction
models, as we aimed to use only information that is available
upon admission to the hospital. In this way, our models can be
used to inform neurologists and patients in the very acute
stage.
In a previous study, we showed strong predictive values of
individual abnormal imaging measures for prediction of func-
tional outcome after 90 days in univariable analyses [17].
However, using the same type of modeling as we performed
in the present study, there was no additional value of CTA or
CTP measures when they were added to clinical features and
NCCT. The differences between these two studies can be ex-
plained by infarct location [47] and by factors other than ad-
mission imaging findings that can also determine the clinical
outcome after 90 days, including occurrence of another infarct
[48] and post-stroke infections [49].
We acknowledge some limitations to our study. Infarct size
was measured on either CT or MRI. As the default follow-up
modality was NCCT, it is possible that some smaller infarcts
were not detected. Median infarct volumes were larger on
follow-up NCCT than on follow-up MRI, which can be ex-
plained by the fact that MRI was performed instead of NCCT
when there was a strong suspicion of an infarct, but admission
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CT did not show any abnormalities. However, as the results
were similar when we repeated the analyses without pa-
tients with MRI as follow-up modality, it is unlikely that
this has caused a major bias. In addition, infarct volume
was measured after 3 days which could have led to an
overestimation of the true infarct volume due to the pres-
ence of cytotoxic edema, as it has been shown that infarct
volume is smaller after 3 months [50]. Infarct volumes on
MRI were measured on DWI, which is reliable but less
accurate when compared with FLAIR lesions after 30 days
[51]. Furthermore, CTP coverage did not include the en-
tire brain. Finally, the regression coefficients of the Tobit
analyses are applicable to the (theoretical) uncensored in-
farct volume values, while in practice, this variable is
censored. Nonetheless, we think that Tobit regression is
still the most appropriate method to analyze our data.
Conclusions
This study showed that adding CTA and CTP measures to
patient characteristics and NCCT improves prediction of in-
farct presence and infarct volume on follow-up imaging. CTA
and CTP help the clinician to predict which patients with acute
anterior circulation stroke symptoms actually develop an in-
farct and to predict the infarct volume. These results could be
used for patient selection in future trials on treatment of acute
ischemic stroke.
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